Drugmaker Leo Pharma Is Said to Pick Banks for Copenhagen IPO
Drugmaker Leo Pharma AS has lined up investment banks to lead a potential initial public offering as soon…
Lilly’s FDA-approved oral weight-loss pill puts Novo Nordisk’s Wegovy franchise under fresh pressure
GLP-1 wars: Lilly’s FDA-approved oral weight-loss pill puts Novo Nordisk’s Wegovy franchise under fresh pressure Proactive uses images…
Why The Narrative Around Danske Bank (CPSE:DANSKE) Is Shifting On Fine Tuned Valuations
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Danske…
Wall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit
Novo Nordisk (NVO) cut to Hold, $42 target, down 53.14% past year. Korn Ferry (KFY) target cut to…
Morgan Stanley Upgrades Novo Nordisk A/S (NVO) to Equal Weight From Underweight – Here’s Why
Novo Nordisk A/S (NYSE:NVO) is one of the best undervalued stocks to invest in right now. Morgan Stanley…
Looking at the Narrative for Danske Bank Amid Shifting Analyst Expectations
Danske Bank’s consensus analyst price target has inched higher, moving from DKK 296.07 to DKK 298.64. This shift…